Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: A meta-analysis

Diseases of the Esophagus

Volumn 27, Issue 7, 2014, Pages 645-653

  Nie, S ^a,b   Chen, T ^a   Yang, X ^a   Huai, P ^b   Lu, M ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Helicobacter pylori; Meta analysis

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; ASIA; CHINA; DATA EXTRACTION; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYNTHESIS; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; METABOLISM; MICROBIOLOGY; RISK;

ADENOCARCINOMA; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ODDS RATIO;

EID: 84906789897     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12194     Document Type: Article

References (62)

1. Sachs G, Scott D R. Helicobacter pylori: eradication or preservation. F1000 Med Rep 2012; 4: 7.
2. Arkkila P E, Kokkola A, Seppala K, Sipponen P. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol 2007; 42: 695-701.
3. Li X B, Ge Z Z, Chen X Y, Liu W Z. Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis. Braz J Med Biol Res 2007; 40: 897-902.
4. Mhaskar R S, Ricardo I, Azliyati A etal. Assessment of risk factors of Helicobacter pylori infection and peptic ulcer disease. J Glob Infect Dis 2013; 5: 60-67.
5. Huang J Q, Zheng G F, Sumanac K, Irvine E J, Hunt R H. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636-1644.
6. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
7. Wang C, Yuan Y, Hunt R H. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007; 102: 1789-1798.
8. Bourke B. Will treatment of Helicobacter pylori infection in childhood alter the risk of developing gastric cancer? Can J Gastroenterol 2005; 19: 409-411.
9. Stolzenberg-Solomon R Z, Blaser M J, Limburg P J etal. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93: 937-941.
10. Raderer M, Wrba F, Kornek G etal. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55: 16-19.
11. Limburg P J, Stolzenberg-Solomon R Z, Colbert L H etal. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11 (10 Pt 1): 1095-1099.
12. Shmuely H, Passaro D, Figer A etal. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96: 3406-3410.
13. Khoshbaten M, Zadimani A, Bonyadi M R, Mohammadzadeh M, Gachkar L, Pourhoseingholi M A. Helicobacter pylori infection reduces the risk of esophageal squamous cell carcinoma: a case-control study in Iran. Asian Pac J Cancer Prev 2011; 12: 149-151.
14. Fruh M, Zhou W, Zhai R etal. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer 2008; 98: 689-692.
15. Kamangar F, Qiao Y L, Blaser M J etal. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007; 96: 172-176.
16. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-694.
17. Chow W H, Blaser M J, Blot W J etal. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588-590.
18. Anderson L A, Murphy S J, Johnston B T etal. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008; 57: 734-739.
19. Siman J H, Engstrand L, Berglund G, Forsgren A, Floren C H. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 2007; 42: 933-940.
20. Iijima K, Koike T, Abe Y etal. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 2007; 102: 1603-1609.
21. El-Omar E M, Rabkin C S, Gammon M D etal. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201.
22. Wu D C, Wu I C, Lee J M etal. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 2005; 100: 588-593.
23. Wells G A, Shea B, O'Connell D etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2000. [Cited 3 Apr 2013.] Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
24. Higgins J P, Thompson S G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
25. Higgins J P, Thompson S G, Deeks J J, Altman D G. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
27. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 8: 15-17.
28. Egger M, Davey S G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
29. Lu H Effect of HPV and HP on the incidence of esophageal cancer and its association with p53 and p63 (Master Thesis). Shijiazhuang, Hebei, China: Hebei Medical University, 2012. (in Chinese).
30. Mao K, Ding X, Cui J, Et A. An analysis of Helicobacter pylori infection for esophageal cancer in high-risk and low-risk areas in southern and northern China. Chin J Diffic and Compl Cas 2011; 10: 676-678. (in Chinese).
31. Cook M B, Dawsey S M, Diaw L etal. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 2010; 19: 1966-1975.
32. Wu I C, Wu D C, Yu F J etal. Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol 2009; 15: 5465-5471.
33. Derakhshan M H, Malekzadeh R, Watabe H etal. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008; 57: 298-305.
34. Zheng Y, Wang S, Yang C. A research of the relationship between the infection of Helicobacter pylori and esophageal squamons cell carcinoma. Int J Dig Dis 2008; 28: 433-434. (in Chinese).
35. Xu H, Wu B. The relationship between infection of HP and disease of upper digestive tract. Mod Med J China 2006; 8: 7-8, (in Chinese).
36. de Martel C, Llosa A E, Farr S M etal. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005; 191: 761-767.
37. Ye W, Held M, Lagergren J etal. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96: 388-396.
38. Wu A H, Crabtree J E, Bernstein L etal. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-821.
39. Wang K X, Wang X F, Peng J L, Cui Y B, Wang J, Li C P. Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol 2003; 9: 2501-2504.
40. Grimley C E, Holder R L, Loft D E, Morris A, Nwokolo C U. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroen Hepat 1999; 11: 503-509.
41. Vicari J J, Peek R M, Falk G W etal. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-57.
42. Qing Y, Chen Y, Xu J, Huang S, Xu Q. Correlation between Helicobacter Pylori infection and esophageal cancer. Pract J Cancer 1998; 13: 35-36. (in Chinese).
43. Talley N J, Zinsmeister A R, Weaver A etal. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739.
44. Venerito M, Kohrs S, Wex T etal. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study. Eur J Gastroenterol Hepatol 2011; 23: 859-864.
45. Hu H M, Kuo C H, Lee C H etal. Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol 2009; 9: 37.
46. Weston A P, Badr A S, Topalovski M, Cherian R, Dixon A, Hassanein R S. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-394.
47. Whiteman D C, Parmar P, Fahey P etal. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139: 73-83. e11-2.
48. Palladino-Davis A G, Mendez B M, Fisichella P M, Davis C S. Dietary habits and esophageal cancer. Dis Esophagus 2013; doi:10.1111/dote.12097 (Epub ahead of print).
49. Iftikhar S Y, James P D, Steele R J, Hardcastle J D, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-1158.
50. Williamson W A, Ellis F J, Gibb S P etal. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212-2216.
51. Richter J E, Falk G W, Vaezi M F. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 1998; 93: 1800-1802.
52. Varanasi R V, Fantry G T, Wilson K T. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998; 3: 188-194.
53. Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2013; 25: 1195-1205.
54. Mager D L. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med 2006; 4: 14.
55. Nwokolo C U, Freshwater D A, O'Hare P, Randeva H S. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003; 52: 637-640.
56. Nakazato M, Murakami N, Date Y etal. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
57. Wren A M, Seal L J, Cohen M A etal. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
58. Spechler S J. Screening and surveillance for complications related to gastroesophageal reflux disease. Am J Med 2001; 111 (8, Suppl. 1): 130-136.
59. Jones A D, Bacon K D, Jobe B A, Sheppard B C, Deveney C W, Rutten M J. Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells. J Gastrointest Surg 2003; 7: 68-76.
60. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008; 1: 329-338.
61. Zhuo X, Zhang Y, Wang Y, Zhuo W, Zhu Y, Zhang X. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol) 2008; 20: 757-762.
62. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007; 5: 1413-1417.